XML 69 R50.htm IDEA: XBRL DOCUMENT
v3.25.0.1

QUARTERLY FINANCIAL DATA (UNAUDITED) (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Quarterly Financial Information Disclosure [Abstract] |
Quarterly Financial Results and Market for Company's Stock | The results of operations of any quarter are not necessarily indicative of the results that may be expected for any future period.
| 2024
(in millions, except per share data) | First Quarter | Second Quarter 2 | Third Quarter | Fourth Quarter 3 | Full Year 1
Net sales | $ | 2,490 |  | $ | 2,694 |  | $ | 2,699 |  | $ | 2,753 |  | $ | 10,636 |
Gross margin | 961 |  | 1,031 |  | 1,033 |  | 959 |  | 3,984 |
Income (loss) from continuing operations | 6 |  | 95 |  | 61 |  | (488) |  | (326) |
Income (loss) from discontinued operations | 33 |  | (406) |  | 83 |  | (22) |  | (312) |
Net income (loss) | 39 |  | (311) |  | 144 |  | (510) |  | (638) |
Net income (loss) attributable to Baxter stockholders | 37 |  | (314) |  | 140 |  | (512) |  | (649) |
Income (loss) from continuing operations per common share |  |  |  |  |
Basic | $ | 0.01 |  | $ | 0.19 |  | $ | 0.12 |  | $ | (0.95) |  | $ | (0.64) |
Diluted | $ | 0.01 |  | $ | 0.19 |  | $ | 0.12 |  | $ | (0.95) |  | $ | (0.64) |
Income (loss) from discontinued operations per common share |  |  |  |  |
Basic | $ | 0.06 |  | $ | (0.81) |  | $ | 0.15 |  | $ | (0.05) |  | $ | (0.63) |
Diluted | $ | 0.06 |  | $ | (0.81) |  | $ | 0.15 |  | $ | (0.05) |  | $ | (0.63) |
Net Income (loss) per common share |  |  |  |  |
Basic | $ | 0.07 |  | $ | (0.62) |  | $ | 0.27 |  | $ | (1.00) |  | $ | (1.27) |
Diluted | $ | 0.07 |  | $ | (0.62) |  | $ | 0.27 |  | $ | (1.00) |  | $ | (1.27) |
| 2023
(in millions, except per share data) | First Quarter | Second Quarter 4 | Third Quarter 5 | Fourth Quarter | Full Year 1
Net sales | $ | 2,441 |  | $ | 2,591 |  | $ | 2,599 |  | $ | 2,729 |  | $ | 10,360 |
Gross margin | 964 |  | 1,030 |  | 1,056 |  | 1,100 |  | 4,150 |
Income (loss) from continuing operations | (48) |  | (27) |  | 37 |  | 219 |  | 181 |
Income from discontinued operations | 93 |  | (112) |  | 2,474 |  | 27 |  | 2,482 |
Net income (loss) | 45 |  | (139) |  | 2,511 |  | 246 |  | 2,663 |
Net income (loss) attributable to Baxter stockholders | 44 |  | (141) |  | 2,508 |  | 245 |  | 2,656 |
Income (loss) from continuing operations per common share |  |  |  |  |
Basic | $ | (0.10) |  | $ | (0.05) |  | $ | 0.07 |  | $ | 0.43 |  | $ | 0.36 |
Diluted | $ | (0.10) |  | $ | (0.05) |  | $ | 0.07 |  | $ | 0.43 |  | $ | 0.36 |
Income from discontinued operations per common share |  |  |  |  |
Basic | $ | 0.19 |  | $ | (0.23) |  | $ | 4.88 |  | $ | 0.05 |  | $ | 4.89 |
Diluted | $ | 0.19 |  | $ | (0.23) |  | $ | 4.86 |  | $ | 0.05 |  | $ | 4.87 |
Net Income (loss) per common share |  |  |  |  |
Basic | $ | 0.09 |  | $ | (0.28) |  | $ | 4.95 |  | $ | 0.48 |  | $ | 5.25 |
Diluted | $ | 0.09 |  | $ | (0.28) |  | $ | 4.93 |  | $ | 0.48 |  | $ | 5.23 |
1 The sum of per share amounts for quarterly periods may not equal full year amounts due to rounding. 2 Our results from discontinued operations for the quarter ended June 30, 2024 included a $430 million charge related to a goodwill impairment of our Chronic Therapies reporting unit within our Kidney Care segment. 3 Our results from continuing operations for the fourth quarter ended December 31, 2024 included a $425 million charge related to a goodwill impairment of our Front Line Care reporting unit within our Healthcare Systems & Technologies segment. 4 Our results from discontinued operations for the quarter ended June 30, 2023 included $243 million of long-lived asset impairment charges resulting from our decision to cease production at one of our dialyzer manufacturing facilities. 5 Our results from discontinued operations for the quarter ended September 30, 2023 included a gain of $2.88 billion from the sale of our BPS business, partially offset by $267 million of long-lived asset impairment charges related to our the hemodialysis business of our former Kidney Care segment.

X
- References No definition available. + Details
Name: | us-gaap_QuarterlyFinancialInformationDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Section 50 -Paragraph 1 -SubTopic 10 -Topic 270 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1 + Details
Name: | us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration